Michael Bell
Vermogen: 6 M $ op 31-05-2026
Vermogen: 6 M $ op 31-05-2026
Momenteel bekleedt Michael Bell de functie van Chief Financial Officer bij Guardant Health, Inc. Voorheen bekleedde de heer Bell de functie van Chief Financial & Chief Accounting Officer bij CareDx, Inc, Chief Financial Officer bij Singulex, Inc, Chief Financial Officer bij Metabiota, Inc, Finance Director bij Chiron Corp, Head-Finance bij Novartis Corp, Chief Financial Officer bij Novartis Vaccines & Diagnostics, Inc, Chief Financial Officer van Novartis Pharma AG, Principal bij Deloitte & Touche LLP en Principal bij Ernst & Young LLP (Missouri). Hij behaalde een bachelorgraad aan de Universiteit van Leicester.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-06-2026 | 48.452 ( 0,04% ) | 6 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GUARDANT HEALTH, INC. | Financieel Directeur/CFO | 05-01-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CAREDX, INC. | Financieel Directeur/CFO | 31-12-2020 |
Metabiota, Inc.
Metabiota, Inc. Miscellaneous Commercial ServicesCommercial Services provides science and data analytics. | Financieel Directeur/CFO | 01-03-2017 |
Singulex, Inc.
Singulex, Inc. Medical SpecialtiesHealth Technology Operates as an immunodiagnostics company | Financieel Directeur/CFO | 01-01-2016 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Financieel Directeur/CFO | 01-01-2012 |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Financieel Directeur/CFO | 01-01-2012 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Singulex, Inc.
Singulex, Inc. Medical SpecialtiesHealth Technology Operates as an immunodiagnostics company | Health Technology |
Metabiota, Inc.
Metabiota, Inc. Miscellaneous Commercial ServicesCommercial Services provides science and data analytics. | Commercial Services |
Guardant Health, Inc.
Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Ernst & Young LLP (Missouri)
Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services | Commercial Services |
University of Leicester
University of Leicester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau